Reactive oxygen species as mediator of tumor radiosensitivity

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 4, 2014, Pages 811-818

  Dayal, Renu ^a   Singh, Amrita ^a   Pandey, Anubhuti ^a   Mishra, Kaushala ^a  

^a Nehru Gram Bharati University   (India)

Author keywords

Antioxidants; oxidative stress; radiation; reactive oxygen species; tumor radiosensitivity; tumor toxicity

Indexed keywords

ANTIOXIDANT; CURCUMIN; CYCLINE; ETOPOSIDE; FISETIN; FREE RADICAL; HERBACEOUS AGENT; OXYGEN; PLANT EXTRACT; PROTEIN P53; RADIOSENSITIZING AGENT; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CANCER RADIOTHERAPY; CYTOTOXICITY; DNA CLEAVAGE; DOUBLE STRANDED DNA BREAK; GENOMIC INSTABILITY; HUMAN; NONHUMAN; OXIDATIVE STRESS; RADIATION DOSE; RADIATION EXPOSURE; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; METABOLISM; NEOPLASMS;

HUMANS; NEOPLASMS; OXIDATIVE STRESS; RADIATION TOLERANCE; REACTIVE OXYGEN SPECIES;

EID: 84921325256     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.146073     Document Type: Review

References (63)

1. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 2002;192:1-15.
2. Pandey BN, Mishra KP. In-vitro studies on radiation induced membrane oxidative damage in apoptotic death thymocytes. Int J Low Radiat 2003;1:113-9.
3. Rezvani M. Amelioration of the pathological changes induced by radiotherapy in normal tissues. J Pharm Pharmacol 2008;60:1037-48.
4. Wood LJ, Nail LM, Perrin NA, Elsea CR, Fischer A, Druker BJ. The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms. Biol Res Nurs 2006;8:157-69.
5. Patt HM, Tyree EB, Straube RL, Smith DE. Cysteine protection against X irradiation. Science (New York, NY) 1949;110:213-4.
6. Smoluk GD, Fahey RC, Calabro-Jones PM, Aguilera JA, Ward JF. Radioprotection of cells in culture by WR-2721 and derivatives: Form of the drug responsible for protection. Cancer Res 1988;48:3641-7.
7. Kemp G, Rose P, Lurain J, Berman M, Manetta A, Roullet B, et al. Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: Results of a randomized control trial in patients with advanced ovarian cancer. J Clin Oncol 1996;14:2101-12.
8. Kouvaris JR, Kouloulias VE, Vlahos LJ. Amifostine: The first selective-target and broad-spectrum radioprotector. Oncologist 2007;12:738-47.
9. Grdina DJ, Murley JS, Kataoka Y, Baker KL, Kunnavakkam R, Coleman MC, et al. Amifostine induces antioxidant enzymatic activities in normal tissues and a transplantable tumor that can affect radiation response. Int J Radiat Oncol Biol Phys 2009;73:886-96.
10. Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000;18:3339-45.
11. Zabbarova I, Kanai A. Targeted delivery of radioprotective agents to mitochondria. Mol Interv 2008;8:294-302.
12. Sandhya T, Lathika KM, Pandey BN, Bhilwade HN, Chaubey RC, Priyadarsini KI, et al. Protection against radiation oxidative damage in mice by Triphala. Mutat Res 2006;609:17-25.
13. Kumar KS, Raghavan M, Hieber K, Ege C, Mog S, Parra, N et al. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant γ-tocotrienol. Life Sci 2006;78:2099-104.
14. Tiwari S, Bala M. Hippophae leaves prevent immunosuppression and inflammation in 60Co-γ-irradiated mice. Phytopharmacol 2011;1:36-48.
15. Jagetia GC. Radioprotection and radiosensitization by curcumin. In: The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease. USA: Springer; 2007. p. 301-20.
16. Goel A, Aggarwal BB. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer 2010;62:919-30.
17. Martin KR, Barrett JC. Reactive oxygen species as double-edged swords in cellular processes: Low-dose cell signaling versus high-dose toxicity. Hum Exp Toxicol 2002;21:71-5.
18. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.
19. Güngör N, Knaapen AM, Munnia A, Peluso M, Haenen GR, Chiu RK, et al. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis 2010;25:149-54.
20. Halliwell B, Gutteridge JM, editors. Free Radical Biology and Medicine. Oxford: Calendron Press; 1989.
21. Belli M, Sapora O, Tabocchini MA. Molecular targets in cellular response to ionizing radiation and implications in space radiation protection. J Radiat Res 2002;43 Suppl: S13-9.
22. Grady WM. Genomic instability and colon cancer. Cancer Metastasis Rev 2004;23:11-27.
23. Chung YM, Bae YS, Lee SY. Molecular ordering of ROS production, mitochondrial changes and caspase activation during sodium salicylate-induced apoptosis. Free Radic Biol Med 2003;34:434-42.
24. Schraufstätter I, Hyslop PA, Jackson JH, Cochrane CG. Oxidant-induced DNA damage of target cells. J Clin Invest 1988;82:1040-50.
25. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol 2000;18:2626-34.
26. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
27. Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000;29:323-33.
28. Loo G. Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation. J Nutr Biochem 2003;14:64-73.
29. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006;12:440-50.
30. Günther C, Martini E, Wittkopf N, Amann K, Weigmann B, Neumann H, et al. Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. Nature 2011;477:335-9.
31. Gazda MJ, Coia LR. Principles of radiation therapy. In: Pazdur R, Coia LR, Hosians WJ, Wagman LD, editors. Cancer Management: A Multidisciplinary Approach: Medical, surgical and radiation oncology. Melville: PRR, Inc; 2001. p. 9-19.
32. Borek C. Antioxidants and radiation therapy. J Nutr 2004;134:3207-9S.
33. Ross GM. Induction of cell death by radiotherapy. Endocr Relat Cancer 1999;6:41-4.
34. Stone HB, McBride WH, Coleman CN. Modifying normal tissue damage postirradiation: Report of a Workshop Sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland September 6-8, 2000. Radiat Res 2002;157:204-23.
35. Prasanna PG, Stone HB, Wong RS, Capala J, Bernhard EJ, Vikram B, et al. Normal tissue protection for improving radiotherapy: Where are the gaps Transl Cancer Res 2012;1:35-48.
36. Hu J, Van Valckenborgh E, Xu D, Menu E, De Raeve H, De Bryune E, et al. Synergistic induction of apoptosis in multiple myeloma cells by bortezomib and hypoxia-activated prodrug TH-302, in vivo and in vitro. Mol Cancer Ther 2013;12:1763-73.
37. Affolter A, Drigotas M, Fruth K, Schmidtmann I, Brochhausen C, Mann WJ, et al. Increased radioresistance via G12S K-Ras by compensatory upregulation of MAPK and PI3K pathways in epithelial cancer. Head Neck 2013;35:220-8.
38. Drigotas M, Affolter A, Mann WJ, Brieger J. Reactive oxygen species activation of MAPK pathway results in VEGF upregulation as an undesired irradiation response. J Oral Pathol Med 2013;42:612-9.
39. Prasad KN, Cole WC, Kumar B, Che Prasad K. Pros and cons of antioxidant use during radiation therapy. Cancer Treat Rev 2002;28:79-91.
40. Sinclair WK. Cysteamine: Differential X-ray protective effect on Chinese hamster cells during the cell cycle. Science 1968;159:442-4.
41. Mertens-Talcott SU, Percival SS. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 2005;218:141-51.
42. Bhosle SM, Huilgol NG, Mishra KP. Enhancement of radiation-induced oxidative stress and cytotoxicity in tumor cells by ellagic acid. Clin Chim Acta 2005;359:89-100.
43. Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009;458:780-3.
44. Seong KM, Kim CS, Jeon HY, Oh SH, Nam SY, Yang KH, et al. Intrinsic radiosensitivity correlated with radiation-induced ROS and cell cycle regulation. Mol Cell Toxicol 2010;6:1-7.
45. Prasad KN. Rationale for using high-dose multiple dietary antioxidants as an adjunct to radiation therapy and chemotherapy. J Nutr 2004;134:3182-3S.
46. Puthli A, Tiwari R, Mishra KP. Biochanin A enhances the radiotoxicity in colon tumor cells in vitro. J Environ Pathol Toxicol Oncol 2013;32:189-203.
47. Khafif AV, Hurst R, Kyker K, Fliss DM, Gil Z, Medina JE. Curcumin: A new radio-sensitizer of squamous cell carcinoma cells. Otolaryngol Head Neck Surg 2005;132:317-21.
48. Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clinic Cancer Res 2005;11:2735-46.
49. Phetkate P, Kummal T, U-Pratya Y, Kietinum S. Significant increase in cytotoxic T lymphocytes and natural killer cells by Triphala: A clinical phase I study. Evid Based Complement Alternat Med 2012;2012:239-856.
50. Girdhani S, Bhosle SM, Thulsidas SA, Kumar A, Mishra KP. Potential of radiosensitizing agents in cancer chemo-radiotherapy. J Can Res Ther 2005;1:129-31.
51. Geetha S, Ram MS, Sharma SK, Ilavazhagan G, Banerjee PK, Sawhney RC. Cytoprotective and antioxidant activity of seabuckthorn (Hippophae rhamnoides L.) flavones against tert-butyl hydroperoxide-induced cytotoxicity in lymphocytes. J Med Food 2009;12:151-8.
52. Christofidou-Solomidou M, Tyagi S, Pietrofesa R, Dukes F, Arguiri E, Turowski J, et al. Radioprotective role in lung of the flaxseed lignan complex enriched in the phenolic secoisolariciresinol diglucoside (SDG). Radiat Res 2012;178:568-80.
53. Chard RL Jr, Krivit W, Bleyer WA, Hammond D. Phase II study of VP-16-213 in childhood malignant disease: A Children's Cancer Study Group Report. Cancer Treat Rep 1978;63:1755-9.
54. Slater LM, Murray SL, Wetzel MW, Sweet P, Stupecky M. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance. Cancer Chemother Parmacol 1986;16:50-4.
55. Hazra B, Ghosh S, Kumar A, Pandey BN. The prospective role of plant products in radiotherapy of cancer: A current overview. Front Pharmacol 2011;2:94.
56. Adhvaryu MR, Reddy N, Parabia MH. Anti-tumor activity of four Ayurvedic herbs in Dalton lymphoma ascites bearing mice and their short-term in vitro cytotoxicity on DLA-cell-line. Afr J Tradit Complement Altern Med 2008;5:409-18.
57. Singh SP, Abraham SK, Kesavan PC. Radioprotection of mice following garlic pretreatment. Br J Cancer Suppl 1996;27:S102-4.
58. Sagar SM, Wong RK. Increasing Therapeutic Gain and Controlling Radiation-Induced Injuries with Asian Botanicals and Acupuncture. In: Cho WC editor. Supportive Cancer Care with Chinese Medicine. Netherlands: Springer; 2010. p. 109-39.
59. McIlwraith AJ, Vasey PA, Ross GM, Brown R. Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res 1994;54:3718-22.
60. Cermak R, Wolffram S. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms. Curr Drug Metab 2006;7:729-44.
61. Catterall F, King LJ, Clifford MN, Ioannidis C. Bioavailability of dietary doses of 3H-labelled tea antioxidants (+)-catechin and (-)-epicatechin in rat. Xenobiotica 2003;33:743-53.
62. Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 2008;17:1411-7.
63. Shia CS, Tsai SY, Kuo SC, Hou YC, Chao PD. Metabolism and pharmacokinetics of 3,3¢,4¢,7-tetrahydroxyflavone (fisetin), 5-hydroxyflavone and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites. J Agric Food Chem 2008;57:83-9.